TP53 and cancer: Compared with the other subtypes, p53 abn was associated with older age, larger tumors on preoperative ultrasound, non‐endometrioid cancer, higher cancer stage, more advanced postoperative ESMO risk group, higher likelihood of death from disease and lower 5‐year disease‐free survival and overall survival.